416 related articles for article (PubMed ID: 18927284)
41. The DNA helicases acting in nucleotide excision repair, XPD, CSB and XPB, are not required for PCNA-dependent repair of abasic sites.
Cappelli E; Carrozzino F; Abbondandolo A; Frosina G
Eur J Biochem; 1999 Jan; 259(1-2):325-30. PubMed ID: 9914510
[TBL] [Abstract][Full Text] [Related]
42. Transcription-coupled nucleotide excision repair is coordinated by ubiquitin and SUMO in response to ultraviolet irradiation.
Liebelt F; Schimmel J; Verlaan-de Vries M; Klemann E; van Royen ME; van der Weegen Y; Luijsterburg MS; Mullenders LH; Pines A; Vermeulen W; Vertegaal ACO
Nucleic Acids Res; 2020 Jan; 48(1):231-248. PubMed ID: 31722399
[TBL] [Abstract][Full Text] [Related]
43. Competent transcription initiation by RNA polymerase II in cell-free extracts from xeroderma pigmentosum groups B and D in an optimized RNA transcription assay.
Satoh MS; Hanawalt PC
Biochim Biophys Acta; 1997 Nov; 1354(3):241-51. PubMed ID: 9427533
[TBL] [Abstract][Full Text] [Related]
44. Sirt1 suppresses RNA synthesis after UV irradiation in combined xeroderma pigmentosum group D/Cockayne syndrome (XP-D/CS) cells.
Vélez-Cruz R; Zadorin AS; Coin F; Egly JM
Proc Natl Acad Sci U S A; 2013 Jan; 110(3):E212-20. PubMed ID: 23267107
[TBL] [Abstract][Full Text] [Related]
45. Cerebro-oculo-facio-skeletal syndrome.
Suzumura H; Arisaka O
Adv Exp Med Biol; 2010; 685():210-4. PubMed ID: 20687508
[TBL] [Abstract][Full Text] [Related]
46. Cockayne's Syndrome A and B Proteins Regulate Transcription Arrest after Genotoxic Stress by Promoting ATF3 Degradation.
Epanchintsev A; Costanzo F; Rauschendorf MA; Caputo M; Ye T; Donnio LM; Proietti-de-Santis L; Coin F; Laugel V; Egly JM
Mol Cell; 2017 Dec; 68(6):1054-1066.e6. PubMed ID: 29225035
[TBL] [Abstract][Full Text] [Related]
47. The Cockayne syndrome B protein, involved in transcription-coupled DNA repair, resides in an RNA polymerase II-containing complex.
van Gool AJ; Citterio E; Rademakers S; van Os R; Vermeulen W; Constantinou A; Egly JM; Bootsma D; Hoeijmakers JH
EMBO J; 1997 Oct; 16(19):5955-65. PubMed ID: 9312053
[TBL] [Abstract][Full Text] [Related]
48. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
[TBL] [Abstract][Full Text] [Related]
49. Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.
Kuschal C; Thoms KM; Boeckmann L; Laspe P; Apel A; Schön MP; Emmert S
Exp Dermatol; 2011 Oct; 20(10):795-9. PubMed ID: 21707758
[TBL] [Abstract][Full Text] [Related]
50. DMBA-induced toxic and mutagenic responses vary dramatically between NER-deficient Xpa, Xpc and Csb mice.
Wijnhoven SW; Kool HJ; Mullenders LH; Slater R; van Zeeland AA; Vrieling H
Carcinogenesis; 2001 Jul; 22(7):1099-106. PubMed ID: 11408355
[TBL] [Abstract][Full Text] [Related]
51. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
[TBL] [Abstract][Full Text] [Related]
52. Retroviral-mediated correction of DNA repair defect in xeroderma pigmentosum cells is associated with recovery of catalase activity.
Quilliet X; Chevallier-Lagente O; Zeng L; Calvayrac R; Mezzina M; Sarasin A; Vuillaume M
Mutat Res; 1997 Dec; 385(3):235-42. PubMed ID: 9506892
[TBL] [Abstract][Full Text] [Related]
53. Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents.
Uboldi S; Bernasconi S; Romano M; Marchini S; Fuso Nerini I; Damia G; Ganzinelli M; Marangon E; Sala F; Clivio L; Chiorino G; Di Giandomenico S; Rocchi M; Capozzi O; Margison GP; Watson AJ; Caccuri AM; Pastore A; Fossati A; Mantovani R; Grosso F; Tercero JC; Erba E; D'Incalci M
Int J Cancer; 2012 Jul; 131(1):59-69. PubMed ID: 21805478
[TBL] [Abstract][Full Text] [Related]
54. Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin.
Stubbert LJ; Smith JM; McKay BC
BMC Cancer; 2010 May; 10():207. PubMed ID: 20470425
[TBL] [Abstract][Full Text] [Related]
55. Cockayne syndrome group A and ferrochelatase finely tune ribosomal gene transcription and its response to UV irradiation.
Lanzafame M; Branca G; Landi C; Qiang M; Vaz B; Nardo T; Ferri D; Mura M; Iben S; Stefanini M; Peverali FA; Bini L; Orioli D
Nucleic Acids Res; 2021 Nov; 49(19):10911-10930. PubMed ID: 34581821
[TBL] [Abstract][Full Text] [Related]
56. Development of a new easy complementation assay for DNA repair deficient human syndromes using cloned repair genes.
Carreau M; Eveno E; Quilliet X; Chevalier-Lagente O; Benoit A; Tanganelli B; Stefanini M; Vermeulen W; Hoeijmakers JH; Sarasin A
Carcinogenesis; 1995 May; 16(5):1003-9. PubMed ID: 7767957
[TBL] [Abstract][Full Text] [Related]
57. RNA polymerase II elongation complexes containing the Cockayne syndrome group B protein interact with a molecular complex containing the transcription factor IIH components xeroderma pigmentosum B and p62.
Tantin D
J Biol Chem; 1998 Oct; 273(43):27794-9. PubMed ID: 9774388
[TBL] [Abstract][Full Text] [Related]
58. Heterogeneity and overlaps in nucleotide excision repair disorders.
Ferri D; Orioli D; Botta E
Clin Genet; 2020 Jan; 97(1):12-24. PubMed ID: 30919937
[TBL] [Abstract][Full Text] [Related]
59. The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum.
Brooks PJ
Neuroscience; 2007 Apr; 145(4):1407-17. PubMed ID: 17184928
[TBL] [Abstract][Full Text] [Related]
60. Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric study.
Schöffski P; Taron M; Jimeno J; Grosso F; Sanfilipio R; Casali PG; Le Cesne A; Jones RL; Blay JY; Poveda A; Maki RG; Nieto A; Tercero JC; Rosell R
Eur J Cancer; 2011 May; 47(7):1006-12. PubMed ID: 21376569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
